Your browser doesn't support javascript.
loading
Pyk2 promotes tumor progression in multiple myeloma.
Zhang, Yu; Moschetta, Michele; Huynh, Daisy; Tai, Yu-Tzu; Zhang, Yong; Zhang, Wenjing; Mishima, Yuji; Ring, Jennifer E; Tam, Winnie F; Xu, Qunli; Maiso, Patricia; Reagan, Michaela; Sahin, Ilyas; Sacco, Antonio; Manier, Salomon; Aljawai, Yosra; Glavey, Siobhan; Munshi, Nikhil C; Anderson, Kenneth C; Pachter, Jonathan; Roccaro, Aldo M; Ghobrial, Irene M.
Affiliation
  • Zhang Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; The First People's Hospital of Yunnan Province, Department of Gastroenterology, Kunming, China;
  • Moschetta M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Huynh D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Tai YT; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Zhang Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Zhang W; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Nanfang Hospital, Southern Medical University, Guangzhou, China; and.
  • Mishima Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Ring JE; Verastem Inc., Cambridge, MA.
  • Tam WF; Verastem Inc., Cambridge, MA.
  • Xu Q; Verastem Inc., Cambridge, MA.
  • Maiso P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Reagan M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Sahin I; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Sacco A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Manier S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Aljawai Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Glavey S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Munshi NC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Anderson KC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Pachter J; Verastem Inc., Cambridge, MA.
  • Roccaro AM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Ghobrial IM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
Blood ; 124(17): 2675-86, 2014 Oct 23.
Article in En | MEDLINE | ID: mdl-25217697
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Xenograft Model Antitumor Assays / Protein Kinase Inhibitors / Focal Adhesion Kinase 2 / Aminopyridines / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Xenograft Model Antitumor Assays / Protein Kinase Inhibitors / Focal Adhesion Kinase 2 / Aminopyridines / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: United States